David Remick is currently a Senior Advisor in Pharmaceutics at Eli Lilly and Company, where they have been employed since 2008. They oversee a solid-state pharmaceutics team and have developed advanced research methods in crystallization and characterization throughout a compound's life cycle. Previously, David held various scientific positions at SSCI, Inc. and Metabasis Therapeutics, where they focused on solid-state properties and organic synthesis, respectively. David is pursuing a Bachelor of Science in Chemistry at UC San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices